Bentall vs Valve-Sparing Aortic Root Replacement.
Aortic root aneurysm — dilation of the aortic root encompassing the sinuses of Valsalva, the aortic annulus, and the sinotubular junction — requires surgical intervention when it reaches 5.0-5.5 cm (or smaller in connective tissue disorders). Valve-sparing root replacement offers the significant advantage of preserving the native valve, eliminating anticoagulation and prosthesis-related complications. An independent Heart Team second opinion can confirm which option is right for your specific anatomy, comorbidities, and goals. Get a Heart Team review →
Aortic root aneurysm — dilation of the aortic root encompassing the sinuses of Valsalva, the aortic annulus, and the sinotubular junction — requires surgical intervention when it reaches 5.0-5.5 cm (or smaller in connective tissue disorders). Two fundamental approaches exist: the Bentall procedure, which replaces the entire root including the aortic valve with a composite valved conduit, and valve-sparing root replacement (VSRR), which replaces the aortic root while preserving the patient's native aortic valve. The Bentall procedure has been the gold standard since its introduction in 1968, offering predictable and reproducible results. Valve-sparing root replacement, pioneered by Tirone David (reimplantation, David procedure) and Magdi Yacoub (remodeling), emerged in the 1990s as a way to avoid the consequences of prosthetic valve implantation — particularly lifelong anticoagulation with a mechanical valve or limited durability with a bioprosthetic valve. The choice depends on the quality of the native aortic valve leaflets, the underlying pathology (connective tissue disorder vs degenerative), surgeon expertise, and patient factors. This is one of the most technically demanding decisions in cardiac surgery, where a second opinion can be invaluable.
Head-to-head comparison.
Bentall
The Bentall procedure replaces the entire aortic root — including the aortic valve, sinuses of Valsalva, and ascending aorta — with a composite graft consisting of a prosthetic valve (mechanical or bioprosthetic) sewn into a Dacron tube graft. The coronary arteries are reimplanted into the graft as buttons. It is the most widely performed aortic root operation worldwide.
Valve-Sparing
Valve-sparing root replacement preserves the native aortic valve while replacing the diseased sinuses and ascending aorta with a Dacron graft. The David (reimplantation) technique suspends the valve inside the graft, providing annular stabilization. The Yacoub (remodeling) technique reshapes the root around the valve without annular support. Most contemporary surgeons favor the David technique for its superior annular stabilization.
Key clinical trials.
What the guidelines say.
The 2022 ACC/AHA Aortic Disease Guidelines recommend valve-sparing root replacement as a reasonable alternative to Bentall for patients with aortic root aneurysm and structurally normal aortic valve leaflets, when performed by experienced surgeons at experienced centers (Class IIa). For Marfan syndrome patients with normal leaflets, VSRR is specifically recommended. The guidelines emphasize that valve-sparing operations should only be performed at centers with documented VSRR expertise and outcomes.
Why the Heart Team matters.
The Bentall vs valve-sparing decision is among the most consequential and surgeon-dependent in cardiac surgery. It requires expert echocardiographic assessment of valve leaflet morphology, root geometry measurement, and evaluation by a surgeon experienced in both techniques. A cardiologist evaluates root dimensions and valve function, while the surgeon assesses leaflet quality intraoperatively and determines VSRR feasibility. WhiteGloveMD provides a second opinion on whether valve-sparing is feasible and whether the patient should seek a referral to a dedicated aortic root surgery center.
Valve-sparing root replacement offers the significant advantage of preserving the native valve, eliminating anticoagulation and prosthesis-related complications. However, it is technically demanding and outcomes are highly center- and surgeon-dependent. The Bentall procedure remains an excellent, reproducible option when valve-sparing is not feasible or when surgeon expertise is limited. Young patients with normal leaflets should strongly consider VSRR at an experienced center.
Frequently asked questions.
How do I know if my valve can be spared?
Valve-sparing is generally feasible when the aortic valve leaflets are structurally normal — thin, pliable, without calcification or fenestrations. Most trileaflet valves in patients with root aneurysms from connective tissue disorders or degenerative dilation are candidates. Bicuspid valves can sometimes be spared but with less predictable results. An experienced surgeon makes the final determination intraoperatively.
What is the David procedure?
The David procedure (valve reimplantation) suspends the native aortic valve inside a Dacron graft, providing external support to the aortic annulus. This stabilizes the annulus and prevents late dilation, which is the main cause of recurrent aortic regurgitation. It is the most commonly performed valve-sparing technique worldwide.
What if my spared valve fails later?
If aortic regurgitation develops after VSRR, options include surgical valve replacement (removing the native valve and inserting a prosthesis inside the existing graft) or, in some cases, TAVR. Freedom from significant regurgitation after the David procedure is 90-96% at 10-15 years in experienced centers.
Should I travel to find a VSRR specialist?
Yes, if valve-sparing is important to you. VSRR outcomes are strongly volume-dependent — centers performing >20 cases per year have significantly better results. This is not an operation to have done by a surgeon who performs it rarely. A WhiteGloveMD evaluation can help determine whether VSRR is appropriate and recommend experienced centers.
- Isselbacher EM, Preventza O, Hamilton Black J, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease. Circulation. 2022;146(24):e334-e482.
- Jordan WD Jr, Rovin J, Moainie S, et al. Results of the GORE TAG conformable thoracic stent graft pivotal trial. J Vasc Surg. 2015;61(3):589-595.
- O'Brien SM, Feng L, He X, et al. The Society of Thoracic Surgeons 2018 Adult Cardiac Surgery Risk Models. Ann Thorac Surg. 2018;105(5):1411-1418.
- Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734-745.
Apply this evidence to your actual case.
Get an independent review from a cardiac surgeon and cardiologist in 24 hours after records are received. No referral needed — pricing is shared on your complimentary discovery call.
Or read how we review cases like this one.
Not sure which option is right for you?
Our Heart Team evaluates your specific anatomy, risk factors, and goals to recommend the best approach. 24-hour turnaround.